Does asthma-bronchiectasis overlap syndrome (ABOS) really exist?

References

• https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf [accessed 10 November 2022]
   Google Scholar
• Casas-Maldonado F, Álvarez-Gutiérrez FJ, Blanco-Aparicio M, Domingo-Ribas C, Cisneros-Serrano C, Soto-Campos G, Román-Bernal B, González-Barcala FJ. Monoclonal antibody treatment for severe uncontrolled asthma in Spain: analytical map. J Asthma. 2022; 59(10):1997–2007.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Barcala FJ, Aboal J, Carreira JM, Rodriguez-Alvarez MX, Puga A, Sanjose E, Pintos M, Valdes L. Trends of asthma mortality in Galicia from 1993 to 2007. J Asthma. 2012; 49(10):1016–1020. doi:10.3109/02770903.2012.728272.
   PubMedGoogle Scholar
• Gonzalez Barcala FJ, La Fuente-Cid RD, Alvarez-Gil R, Tafalla M, Nuevo J, Caamaño-Isorna F. Factors associated with a higher prevalence of work disability among asthmatic patients. J Asthma. 2011; 48(2):194–199. doi:10.3109/02770903.2010.539294.
   PubMed Web of Science ®Google Scholar
• González Barcala FJ, de la Fuente-Cid R, Alvarez-Gil R, Tafalla M, Nuevo J, Caamaño-Isorna F. Factors associated with asthma control in primary care patients: the CHAS study. Arch Bronconeumol. 2010; 46(7):358–363. doi:10.1016/S1579-2129(10)70085-9.
   PubMed Web of Science ®Google Scholar
• Perpiñá Tordera MÁ, Gutiérrez FJ, Blanco Aparicio M. Asthma exists in older people too. Arch Bronconeumol. 2022;58(5):390–391. doi:10.1016/j.arbres.2022.02.010.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Polverino E, Aksamit T. Bronchiectasis and chronic airway disease: it is not just about asthma and COPD. Chest. 2018; 154(4):737–739. doi:10.1016/j.chest.2018.02.024.
   PubMed Web of Science ®Google Scholar
• Martínez-García MÁ, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, Cantón R, Vendrell M, Polverino E, de Gracia J, et al. Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults. Arch Bronconeumol (Engl Ed). 2018;54(2):79–87. doi:10.1016/j.arbr.2017.07.013.
   PubMed Web of Science ®Google Scholar
• Xu JF, Gao YH, Guan WJ. Advances in bronchiectasis registries: the new Chinese registry. Arch Bronconeumol. 2022; 58(11):739–741. doi:10.1016/j.arbres.2022.06.002.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med. 2018; 6(9):715–726. doi:10.1016/S2213-2600(18)30053-5.
   PubMed Web of Science ®Google Scholar
• Ringshausen FC, Rademacher J, Pink I, de Roux A, Hickstein L, Ploner T, Welte T, Diel R. Increasing bronchiectasis prevalence in Germany, 2009–2017: a population-based cohort study. Eur Respir J. 2019; 54(6):1900499. doi:10.1183/13993003.00499-2019.
   PubMed Web of Science ®Google Scholar
• Scioscia G, Alcaraz-Serrano V, Méndez R, Gabarrús A, Fernández-Barat L, Menéndez R, Tondo P, Bueno L, Torres A. Factors associated with one-year mortality in hospitalised patients with exacerbated bronchiectasis. Arch Bronconeumol. 2022; 58(11):773–775. doi:10.1016/j.arbres.2022.04.008.
   PubMed Web of Science ®Google Scholar
• Martínez-García MÁ. Bronchiectasis and eosinophils. Arch Bronconeumol. 2021; 57(11):671–672. doi:10.1016/j.arbres.2021.08.001.
   PubMed Web of Science ®Google Scholar
• Maspero J, Adir Y, Al-Ahmad M, Celis-Preciado CA, Colodenco FD, Giavina-Bianchi P, Lababidi H, Ledanois O, Mahoub B, Perng DW, et al. Type 2 inflammation in asthma and other airway diseases. ERJ Open Res. 2022;8(3):576–2021. doi:10.1183/23120541.00576-2021.
   PubMedGoogle Scholar
• Long MB, Chalmers JD. Treating neutrophilic inflammation in airways diseases. Arch Bronconeumol. 2022; 58(6):463–465. doi:10.1016/j.arbres.2021.11.003.
   PubMed Web of Science ®Google Scholar
• García-Río F, Alcázar-Navarrete B, Castillo-Villegas D, Cilloniz C, García-Ortega A, Leiro-Fernández V, Lojo-Rodriguez I, Padilla-Galo A, Quezada-Loaiza CA, Rodriguez-Portal JA, et al. Biological biomarkers in respiratory diseases. Arch Bronconeumol. 2022;58(4):323–333. doi:10.1016/j.arbres.2022.01.003.
   PubMed Web of Science ®Google Scholar
• Matamala N, Lara B, Gómez-Mariano G, Martínez S, Vázquez-Domínguez I, Otero-Sobrino Á, Muñoz-Callejas A, Sánchez E, Esquinas C, Bustamante A, et al. miR-320c regulates SERPINA1 expression and is induced in patients with pulmonary disease. Arch Bronconeumol. 2021;57(7):457–463. doi:10.1016/j.arbres.2020.03.006.
   PubMed Web of Science ®Google Scholar
• Mäntylä J, Mazur W, Törölä T, Bergman P, Saarinen T, Kauppi P. Asthma as aetiology of bronchiectasis in Finland. Respir Med. 2019; 152:105–111. doi:10.1016/j.rmed.2019.04.022.
   PubMed Web of Science ®Google Scholar
• Malipiero G, Paoletti G, Blasi F, Paggiaro P, Senna G, Latorre M, Caminati M, Carpagnano GE, Crimi N, Spanevello A, et al. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry. Expert Rev Respir Med. 2021;15(3):419–424. doi:10.1080/17476348.2021.1840983.
   PubMed Web of Science ®Google Scholar
• Solarat B, Perea L, Faner R, de La Rosa D, Martínez-García MÁ, Sibila O. Pathophysiology of chronic bronchial infection in bronchiectasis. Arch Bronconeumol. 2023;59(2):101–108. doi:10.1016/j.arbres.2022.09.004.
   Web of Science ®Google Scholar
• González-Barcala FJ, Martínez-Torres AE, Méndez-Brea P, García-Marcos L. With the torch in the mist of the united airway disease: atopic march and other arguments in the search for evidence. Arch Bronconeumol. 2022;58(5):386–387. doi:10.1016/j.arbres.2021.09.017.
   PubMed Web of Science ®Google Scholar
• Alvarez-Gutiérrez FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, González-Barcala FJ, Carretero-Gracia JA, Castilla-Martínez M, Cisneros C, Diaz-Pérez D, Domingo-Ribas C, et al. Consensus document for severe asthma in adults. 2022 update. Open Res Arch. 2022;4(3):100192. doi:10.1016/j.opresp.2022.100192.
   PubMedGoogle Scholar
• Skov IR, Madsen H, Andersen JH, Pottegård A, Davidsen JR. Trends and predictors of specialist assessments in oral corticosteroid treated asthma among young adults. ERJ Open Res. 2022; 8(3):142–2022. doi:10.1183/23120541.00142-2022.
   Google Scholar
• Heffler E, Madeira LNG, Ferrando M, Puggioni F, Racca F, Malvezzi L, Passalacqua G, Canonica GW. Inhaled corticosteroids safety and adverse effects in patients with asthma. J Allergy Clin Immunol Pract. 2018;6(3):776–781. doi:10.1016/j.jaip.2018.01.025.
   PubMed Web of Science ®Google Scholar
• Crimi C, Ferri S, Campisi R, Crimi N. The link between asthma and bronchiectasis: state of the art. Respiration. 2020;99(6):463–476. doi:10.1159/000507228.
   PubMed Web of Science ®Google Scholar
• García-Clemente M, Enríquez-Rodríguez AI, Iscar-Urrutia M, Escobar-Mallada B, Arias-Guillén M, López-González FJ, Madrid-Carbajal C, Pérez-Martínez L, Gonzalez-Budiño T. Severe asthma and bronchiectasis. J Asthma. 2020;57(5):505–509. doi:10.1080/02770903.2019.1579832.
   PubMed Web of Science ®Google Scholar
• Ma D, Cruz MJ, Ojanguren I, Romero-Mesones C, Varona-Porres D, Munoz X. Risk factors for the development of bronchiectasis in patients with asthma. Sci Rep. 2021; 11(1):22820. doi:10.1038/s41598-021-02332-w.
   PubMed Web of Science ®Google Scholar
• Lan G, Huang C, Liu Y, Feng Y, Ni Y, Shi G. How does comorbid bronchiectasis affect asthmatic patients? A meta-analysis. J Asthma. 2021; 58(10):1314–1328. doi:10.1080/02770903.2020.1784194.
   PubMed Web of Science ®Google Scholar
• Padilla-Galo A, Olveira C, Fernández de Rota-Garcia L, Marco-Galve I, Plata AJ, Alvarez A, Rivas-Ruiz F, Carmona-Olveira A, Cebrian-Gallardo JJ, Martinez-Garcia MA. Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients. Respir Res. 2018; 19(1):43. doi:10.1186/s12931-018-0746-7.
   PubMed Web of Science ®Google Scholar
• Sheng H, Yao X, Wang X, Wang Y, Liu X, Zhang L. Prevalence and clinical implications of bronchiectasis in patients with overlapping asthma and chronic rhinosinusitis: a single-center prospective study. BMC Pulm Med. 2021; 21(1):211. doi:10.1186/s12890-021-01575-7.
   PubMed Web of Science ®Google Scholar
• Gibson PG, McDonald VM, Granchelli A, Olin JT. Asthma and comorbid conditions-pulmonary comorbidity. J Allergy Clin Immunol Pract. 2021; 9(11):3868–3875. doi:10.1016/j.jaip.2021.08.028.
   PubMed Web of Science ®Google Scholar
• Kim NY, Lee CH, Jin KN, Lee HW, Heo EY, Kim DK, Lee JK. Clinical deterioration and lung function change in patients with concomitant asthma and bronchiectasis. J Allergy Clin Immunol Pract. 2022; 10(10):2607–2613.e4. doi:10.1016/j.jaip.2022.05.026.
   PubMed Web of Science ®Google Scholar
• Ferri S, Crimi C, Campisi R, Cacopardo G, Paoletti G, Puggioni F, Crimi N, Heffler E. Impact of asthma on bronchiectasis severity and risk of exacerbations. J Asthma. 2022; 59(3):469–475. doi:10.1080/02770903.2020.1857395.
   PubMed Web of Science ®Google Scholar
• Aliberti S, Sotgiu G, Lapi F, Gramegna A, Cricelli C, Blasi F. Prevalence and incidence of bronchiectasis in Italy. BMC Pulm Med. 2020; 20(1):15. doi:10.1186/s12890-020-1050-0.
   PubMed Web of Science ®Google Scholar
• Yang B, Jang HJ, Chung SJ, Yoo SJ, Kim T, Kim SH, Shin YM, Kang HK, Kim JS, Choi H, et al. Factors associated with bronchiectasis in Korea: a national database study. Ann Transl Med. 2020;8(21):1350. doi:10.21037/atm-20-4873.
   PubMed Web of Science ®Google Scholar
• Aliberti S, Amati F, Gramegna A, Vigone B, Oriano M, Sotgiu G, Mantero M, Simonetta E, Saderi L, Stainer A, et al. Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients. ERJ Open Res. 2022;8(1):388–2021. doi:10.1183/23120541.00388-2021.
   Google Scholar
• Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, Polverino E, Van de Kerkhove C, Rutherford R, Davison J, et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12(12):1764–1770. doi:10.1513/AnnalsATS.201507-472OC.
   PubMed Web of Science ®Google Scholar
• Gao YH, Guan WJ, Liu SX, Wang L, Cui JJ, Chen RC, Zhang GJ. Aetiology of bronchiectasis in adults: a systematic literature review. Respirology. 2016; 21(8):1376–1383. doi:10.1111/resp.12832.
   PubMed Web of Science ®Google Scholar
• Sánchez-Muñoz G, López-de-Andrés A, Jiménez-García R, Hernández-Barrera V, Pedraza-Serrano F, Puente-Maestu L, de Miguel-Díez J. Trend from 2001 to 2015 in the prevalence of bronchiectasis among patients hospitalized for asthma and effect of bronchiectasis on the in-hospital mortality. J Asthma. 2021; 58(8):1067–1076. doi:10.1080/02770903.2020.1759086.
   PubMed Web of Science ®Google Scholar
• Liu BC, Huang TX, Yang D, Yang L, Liu CT. Asthma-associated bronchiectasis: more attention needed! Respir Med. 2020; 161:105789. doi:10.1016/j.rmed.2019.09.009.
   PubMed Web of Science ®Google Scholar
• Crimi C, Campisi R, Nolasco S, Ferri S, Cacopardo G, Impellizzeri P, Pistorio MP, Fagone E, Pelaia C, Heffler E, et al. Type 2-high severe asthma with and without bronchiectasis: a prospective observational multicentre study. J Asthma Allergy. 2021;14:1441–1452. doi:10.2147/JAA.S332245.
   PubMed Web of Science ®Google Scholar
• Colomo N, Olveira C, Hernández-Pedrosa J, Bergero T, Fábrega-Ruz J, Porras N, Girón MV, de Rota LF, Olveira G. Validity of self-rating screening scales for the diagnosis of depression and anxiety in adult patients with bronchiectasis. Arch Bronconeumol (Engl Ed). 2021; 57(3):179–185. doi:10.1016/j.arbres.2020.01.009.
   PubMed Web of Science ®Google Scholar
• Sastre J, Crespo A, Fernandez-Sanchez A, Rial M, Plaza V, investigators of the CONCORD Study Group. Anxiety, depression, and asthma control: changes after standardized treatment. J Allergy Clin Immunol Pract. 2018; 6(6):1953–1959. doi:10.1016/j.jaip.2018.02.002.
   PubMed Web of Science ®Google Scholar
• Sawamura MVY, Athanazio RA, Nucci M, Rached SZ, Cukier A, Stelmach R, Assuncao AN, JrTakahashi MS, Nomura CH. Automated computed tomography lung densitometry in bronchiectasis patients. Arch Bronconeumol. 2022;58(6):510–512. doi:10.1016/j.arbres.2021.04.015.
   PubMed Web of Science ®Google Scholar
• Zhang SQ, Xiong XF, Wu ZH, Huang TT, Cheng DY. Clinical features of asthma with comorbid bronchiectasis: a systematic review and meta-analysis. Medicine (Baltimore). 2021; 100(4):e23858. doi:10.1097/MD.0000000000023858.
   PubMed Web of Science ®Google Scholar
• Choi H, Lee H, Ryu J, Chung SJ, Park DW, Sohn JW, Yoon HJ, Kim SH. Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study. Ther Adv Respir Dis. 2020; 14:1753466620963030. doi:10.1177/1753466620963030.
   Web of Science ®Google Scholar
• Ojanguren I, Plaza V. FeNO for Asthma Diagnosis in Adults: More Lights Than Shadows. Arch Bronconeumol (Engl Ed). 2021; 57(2):85–86. doi:10.1016/j.arbres.2020.03.035.
   PubMed Web of Science ®Google Scholar
• Chen FJ, Liao H, Huang XY, Xie CM. Importance of fractional exhaled nitric oxide in diagnosis of bronchiectasis accompanied with bronchial asthma. J Thorac Dis. 2016;8(5):992–999. doi:10.21037/jtd.2016.03.72.
   PubMed Web of Science ®Google Scholar
• Plaza V, Blanco M, García G, Korta J, Molina J, Quirce S, en representación del Comité Ejecutivo de GEMA. Highlights of the Spanish Asthma Guidelines (GEMA), version 5.0. Arch Bronconeumol (Engl Ed). 2021; 57(1):11–12. doi:10.1016/j.arbr.2020.10.010.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Faner R, Oscullo G, de la Rosa D, Soler-Cataluña JJ, Ballester M, Agusti A. Inhaled steroids, circulating eosinophils, chronic airway infection, and pneumonia risk in chronic obstructive pulmonary disease. A network analysis. Am J Respir Crit Care Med. 2020; 201(9):1078–1085. doi:10.1164/rccm.201908-1550OC.
   PubMed Web of Science ®Google Scholar
• Henkle E, Curtis JR, Chen L, Chan B, Aksamit TR, Daley CL, Griffith DE, Winthrop KL. Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. Eur Respir J. 2019; 54(1):1801896. doi:10.1183/13993003.01896-2018.
   PubMed Web of Science ®Google Scholar
• Carpagnano GE, Scioscia G, Lacedonia D, Curradi G, Foschino Barbaro MP. Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab. J Asthma Allergy. 2019; 12:83–90. doi:10.2147/JAA.S196200.
   PubMed Web of Science ®Google Scholar
• Rademacher J, Konwert S, Fuge J, Dettmer S, Welte T, Ringshausen FC. Anti-IL5 and anti-IL5Rα therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series. Eur Respir J. 2020; 55(1):1901333. doi:10.1183/13993003.01333-2019.
   PubMed Web of Science ®Google Scholar
• Blanco-Aparicio M, Calvo-Alvarez U, González-Barcala FJ. Biologics in asthma: don’t let the magic bullets sink the boat. Arch Bronconeumol (Engl Ed). 2021; 57(6):383–384. doi:10.1016/j.arbr.2021.04.004.
   PubMed Web of Science ®Google Scholar
• Choi H, Yang B, Kim YJ, Sin S, Jo YS, Kim Y, Park HY, Ra SW, Oh YM, Chung SJ, et al. Increased mortality in patients with noncystic fibrosis bronchiectasis with respiratory comorbidities. Sci Rep. 2021;11(1):7126. doi:10.1038/s41598-021-86407-8.
   PubMed Web of Science ®Google Scholar
• Crimi C, Campisi R, Nolasco S, Cacopardo G, Intravaia R, Porto M, Impellizzeri P, Pelaia C, Crimi N. Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: a real-world retrospective pilot study. Respir Med. 2021; 185:106491. doi:10.1016/j.rmed.2021.106491.
   PubMed Web of Science ®Google Scholar
• Kudlaty E, Patel GB, Prickett ML, Yeh C, Peters AT. Efficacy of type 2-targeted biologics in patients with asthma and bronchiectasis. Ann Allergy Asthma Immunol. 2021; 126(3):302–304. doi:10.1016/j.anai.2020.11.014.
   PubMed Web of Science ®Google Scholar
• Martínez-García MÁ, Oscullo G, García-Ortega A, Matera MG, Rogliani P, Cazzola M. Inhaled corticosteroids in adults with non-cystic fibrosis bronchiectasis: from bench to bedside. A narrative review. Drugs. 2022; 82(14):1453–1468. doi:10.1007/s40265-022-01785-1.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Posadas T, Sotgiu G, Blasi F, Saderi L, Aliberti S. Repeteability of circulating eosinophil measures and inhaled corticosteroids effect in bronchiectasis. A post hoc analysis of a randomized clinical trial. Arch Bronconeumol (Engl Ed). 2020; 56(10):681–683. doi:10.1016/j.arbres.2020.06.005.
   PubMed Web of Science ®Google Scholar
• Shoemark A, Shteinberg M, De Soyza A, Haworth CS, Richardson H, Gao Y, Perea L, Dicker AJ, Goeminne PC, Cant E, et al. Characterization of eosinophilic bronchiectasis: a European multicohort study. Am J Respir Crit Care Med. 2022;205(8):894–902. doi:10.1164/rccm.202108-1889OC.
   PubMed Web of Science ®Google Scholar